134 related articles for article (PubMed ID: 1816327)
1. Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII.
Johnson WJ; Kilsdonk EP; van Tol A; Phillips MC; Rothblat GH
J Lipid Res; 1991 Dec; 32(12):1993-2000. PubMed ID: 1816327
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-beta high-density lipoprotein particles.
Hennessy LK; Kunitake ST; Kane JP
Biochemistry; 1993 Jun; 32(22):5759-65. PubMed ID: 8504094
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II.
Lagrost L; Dengremont C; Athias A; de Geitere C; Fruchart JC; Lallemant C; Gambert P; Castro G
J Biol Chem; 1995 Jun; 270(22):13004-9. PubMed ID: 7768892
[TBL] [Abstract][Full Text] [Related]
4. Cellular cholesterol efflux. Role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs.
Mahlberg FH; Rothblat GH
J Biol Chem; 1992 Mar; 267(7):4541-50. PubMed ID: 1537840
[TBL] [Abstract][Full Text] [Related]
5. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
Cheung MC; Mendez AJ; Wolf AC; Knopp RH
J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
[TBL] [Abstract][Full Text] [Related]
6. Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII).
Tilly-Kiesi M; Lichtenstein AH; Ordovas JM; Dolnikowski G; Malmström R; Taskinen MR; Schaefer EJ
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):873-80. PubMed ID: 9157950
[TBL] [Abstract][Full Text] [Related]
7. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma.
Cheung MC; Wolf AC; Illingworth DR
Biochim Biophys Acta; 1992 Oct; 1128(2-3):244-9. PubMed ID: 1420297
[TBL] [Abstract][Full Text] [Related]
8. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol.
Komaba A; Li Q; Hara H; Yokoyama S
J Biol Chem; 1992 Sep; 267(25):17560-6. PubMed ID: 1517206
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI.
de Beer MC; Durbin DM; Cai L; Mirocha N; Jonas A; Webb NR; de Beer FC; van Der Westhuyzen DR
J Biol Chem; 2001 May; 276(19):15832-9. PubMed ID: 11279034
[TBL] [Abstract][Full Text] [Related]
10. In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase and apoB-containing lipoproteins.
Cheung MC; Wolf AC
J Lipid Res; 1989 Apr; 30(4):499-509. PubMed ID: 2502592
[TBL] [Abstract][Full Text] [Related]
11. Protein transfer between A-I-containing lipoprotein subpopulations: evidence of non-transferable A-I in particles with A-II.
Cheung MC; Wolf AC; Knopp RH; Foster DM
Biochim Biophys Acta; 1992 Nov; 1165(1):68-77. PubMed ID: 1420350
[TBL] [Abstract][Full Text] [Related]
12. Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol.
Sakai T; Kamanna VS; Kashyap ML
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1783-9. PubMed ID: 11701466
[TBL] [Abstract][Full Text] [Related]
13. Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux.
Oikawa S; Mendez AJ; Oram JF; Bierman EL; Cheung MC
Biochim Biophys Acta; 1993 Jan; 1165(3):327-34. PubMed ID: 8418891
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol efflux from macrophages mediated by high-density lipoprotein subfractions, which differ principally in apolipoprotein A-I and apolipoprotein A-II ratios.
von Hodenberg E; Heinen S; Howell KE; Luley C; Kübler W; Bond HM
Biochim Biophys Acta; 1991 Nov; 1086(2):173-84. PubMed ID: 1932099
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers.
Wang WQ; Moses AS; Francis GA
Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434
[TBL] [Abstract][Full Text] [Related]
16. Influence of apolipoproteins AI, AII, and Cs on the metabolism of membrane and lysosomal cholesterol in macrophages.
Mahlberg FH; Glick JM; Lund-Katz S; Rothblat GH
J Biol Chem; 1991 Oct; 266(30):19930-7. PubMed ID: 1657906
[TBL] [Abstract][Full Text] [Related]
17. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.
Sviridov D; Pyle L; Fidge N
Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173
[TBL] [Abstract][Full Text] [Related]
18. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of triphasic oral contraceptives with desogestrel or levonorgestrel on apolipoprotein A-I-containing high-density lipoprotein particles.
Cheung MC; Walden CE; Knopp RH
Metabolism; 1999 May; 48(5):658-64. PubMed ID: 10337871
[TBL] [Abstract][Full Text] [Related]
20. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma.
Nichols AV; Blanche PJ; Shore VG; Gong EL
Biochim Biophys Acta; 1989 Feb; 1001(3):325-37. PubMed ID: 2492827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
